Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen

Pediatric Allergy and Immunology

Volumn 21, Issue 4 PART2, 2010, Pages

  Jyonouchi, Harumi ^a   Geng, Lee ^a   Cushing Ruby, Agnes ^a   Monteiro, Iona M ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Crohn's disease; Cytokines; Food allergy; Toll like receptors; Ulcerative colitis

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; CANDIDA; CHILD; COMPARATIVE STUDY; CROHN DISEASE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INFANT; MALE; METABOLISM; MICROBIOLOGY; MILK ALLERGY; PATHOLOGY; PRESCHOOL CHILD; SECRETION; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS;

ADOLESCENT; CANDIDA; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; INFANT; MALE; MILK HYPERSENSITIVITY; TH1 CELLS; TH17 CELLS; TOLL-LIKE RECEPTORS;

EID: 79952475871     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00923.x     Document Type: Article

References (37)

1. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol, 2008: 8: 458-66.
2. Rodriguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK. Novel genetic markers in inflammatory bowel disease. World J Gastroenterol, 2007: 13: 5560-70.
3. Van Limbergen J, Russell RK, Nimmo ER, Ho GT, Arnott ID, Wilson DC, Satsangi J. Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis, 2007: 13: 338-55.
4. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol, 2007: 120: 227-235; quiz 36-7.
5. Sicherer SH, Sampson HA. S9. Food allergy. J Allergy Clin Immunol, 2006. 117(2 Suppl. Mini-Primer): S470-5.
6. Banerjee A, Gerondakis S. Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol Cell Biol, 2007: 85: 420-4.
7. Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol, 2008: 4: 34-42.
8. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, Boukhvalova MS, Hemming VG, Blanco JC, Vogel SN. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol, 2007: 179: 3171-7.
9. Tulic MK, Hurrelbrink RJ, Prele CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol, 2007: 179: 132-40.
10. Turvey SE, Hawn TR. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol, 2006: 120: 1-9.
11. Netea MG, Ferwerda G, De Jong DJ, Jansen T, Jacobs L, Kramer M, Naber TH, Drenth JP, Girardin SE, Kullberg BJ, Adema GJ, Van der Meer JW. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol, 2005: 174: 6518-23.
12. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity, 2008: 28: 445-53.
13. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol, 2007: 8: 639-46.
14. Ohsugi Y. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. Biol Pharm Bull, 2007: 30: 2001-6.
15. Mudter J, Neurath MF. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis, 2007: 13: 1016-23.
16. Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, Del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr, 2005: 41: 416-21.
17. Turner D, Otley AR, Mack D, Hyams J, De Bruijne J, Uusoue K, Walters TD, Zachos M, Mamula P, Beaton DE, Steinhart AH, Griffiths AM. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology, 2007: 133: 423-32.
18. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology, 2005: 51: 77-85.
19. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr, 2005: 146: 605-10.
20. Team RDC. R A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2007.
21. Kozyrev SV, Alarcon-Riquelme ME. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity, 2007: 40: 591-601.
22. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem, 2003: 278: 5509-12.
23. Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol, 2008: 126: 121-36.
24. Canto E, Ricart E, Monfort D, Gonzalez-Juan D, Balanzo J, Rodriguez-Sanchez JL, Vidal S. TNF alpha production to TLR2 ligands in active IBD patients. Clin Immunol, 2006: 119: 156-65.
25. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L. IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol, 2007: 8: 369-77.
26. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol, 2007: 8: 345-50.
27. Hecht GA. Inflammatory bowel disease - live transmission. N Engl J Med, 2008: 358: 528-30.
28. Zhang Z, Hinrichs DJ, Lu H, Chen H, Zhong W, Kolls JK. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol, 2007: 7: 409-16.
29. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science, 2007: 317: 256-60.
30. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, De Waal R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol, 2007: 8: 950-7.
31. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol, 2007: 8: 1086-94.
32. Mitsuyama K, Matsumoto S, Masuda J, Yamasakii, H, Kuwaki K, Takedatsu H, Sata M. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease. Anticancer Res, 2007: 27: 3749-56.
33. Du Z, Kelly E, Mecklenbrauker I, Agle L, Herrero C, Paik P, Ivashkiv LB. Selective regulation of IL-10 signaling and function by zymosan. J Immunol, 2006: 176: 4785-92.
34. Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev, 2007: 59: 1073-83.
35. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis, 2006: 12: 1-8.
36. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50years of convergent history. Cytokine Growth Factor Rev, 2008: 19: 3-19.
37. Karlsson MR, Rugtveit J., Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med, 2004: 199: 1679-88.